The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

JOURNAL OF GLAUCOMA is a premier academic journal dedicated to the field of ophthalmology, specializing in glaucoma research and management. Published by Lippincott Williams & Wilkins, this journal plays a pivotal role in disseminating cutting-edge research findings, clinical advancements, and evidence-based practices that address the challenges associated with glaucoma. With an impressive impact factor and categorized in the Q1 quartile in Ophthalmology as of 2023, the journal ranks #38 out of 137 in the Medicine – Ophthalmology category, placing it in the 72nd percentile amongst its peers. Since its inception in 1992, the journal has provided a vital forum for both emerging and established researchers, combining innovative studies with practical insights to enhance patient care. Although the journal is not open access, it remains committed to reaching a wide audience of professionals and students, ensuring they stay abreast of the latest developments in the field. For researchers and practitioners alike, JOURNAL OF GLAUCOMA is an essential resource for advancing knowledge and practices in glaucoma management.

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

TRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.